Come up with a name for your new list and we'll add to it:
Freeline Therapeutics raised a round of funding on June 20, 2016. Investors include
UCL Technology Fund.
Freeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of gene therapies for bleeding and other debilitating disorders.…